Title Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, cond session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.

Publication Info.

Item Status

Location	Call No.	Status	OPAC Message	Public Note	Gift Note
Moore Stacks	5367	Available	---

Description	iv, 319 pages : illustrations ; 24 cm.
Physical Medium	4x6 in.
	monochrome
	positive
Series	S. hrg. ; 102-615
	United States. Congress. Senate. S. hrg. ; 102-615.
Note	Distributed to some depository libraries in microfiche.
	Shipping list no.: 92-0400-P.
Bibliography	Includes bibliographical references.
Note	"Serial no. J-102-48."
Reproduction	Microfiche. [Washington] : Supt Docs/GPO, 1992. 4 microfiche ; 11 x 15 cm.
Subject	Orphan drugs -- Law and legislation -- United States.
	Orphan drugs -- Law and legislation.
	United States.
	Orphan drugs.
	Drugs -- Law and legislation -- United States.
	Drugs -- Law and legislation.
	Antitrust law -- United States.
	Antitrust law.
	Medication.
ISBN	0160386209
Sudoc No.	Y 4.J 89/2:S.hrg.102-615